ArticleTechnology2016

Two-stage nanoparticle delivery of piperlongumine and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) anti-cancer therapy.

Charles C Sharkey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.